Asthma Spacers Market Rise in Demand due to Increasing Uptake of Metered Dose Inhalers

According to our new research study on "Asthma Spacers Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product and Distribution Channel," the market is expected to grow from US$ 1,666.48 million in 2022 to US$ 2,266.47 million by 2028; it is estimated to grow at a CAGR of 5.3% from 2022 to 2028. Rising investments by public and private organizations in R&D activities for product innovation are driving the growth of the global asthma spacers market. However, rising costs of these devices and lack of awareness among people about the product are the factors restraining the market growth.

Download sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00004918/?utm_source=OpenPR&utm_medium=10144

The companies engaged in the asthma spacers market witnessed an adverse impact on their services in early 2020 due to the temporary shutdown of their laboratories. Supply chain and manufacturing activities were disrupted globally due to lockdowns implemented by governments, restricted movement, and other COVID-19 safety precautions. However, the healthcare authorities and government organizations in North America focused on spreading awareness about the COVID-19 pandemic among asthmatic patients as they were highly vulnerable to other lung infections. Such awareness programs positively impacted the adoption of asthma spacers due to preventive measures, which eventually boosted the market for asthma spacers during the COVID-19 pandemic.

Cipla Inc., PARI GmbH, Koninklijke Philips N.V., Lupin, HAAG-STREIT GROUP, Laboratoire ProtecSom, Monaghan Medical Corporation, Koo Medical Equipment, Agaplastic, Metal Zug, and, Teleflex Incorporated are among the key companies operating in the asthma spacers market.

North America is leading the asthma spacers market due to an increasing asthma patient pool and highly sophisticated healthcare infrastructure. According to the Centers for Diseases Control and Prevention (CDC), around 25 million Americans have asthma. This is significantly affecting the sales of asthma spacers. The key companies operating in the asthma spacers market focus on organic and inorganic growth strategies such as product launches and product approvals. They are adopting various methods such as mergers and acquisitions, advanced product development, and collaborations to gain a competitive edge in the market. For instance, in July 2021, Philip Morris International Inc. agreed to buy asthma drugmaker Vectura Group Plc for $ 1.2 billion. The acquisition accelerated PMIs beyond nicotine strategy and expanded its product pipeline development capabilities in inhaled therapeutics.

The product segment in the asthma spacers market is segmented into aerochamber, optichamber, volumatic, and inspirease. The aerochamber segment is expected to hold the largest market share in 2022 and is estimated to register the highest CAGR during 2022-2028. Aerochamber spacer is used along with metered-dose inhaler to improve medication outcomes. The increasing prevalence of respiratory conditions coupled with the growing adoption of inhalers is driving the adoption of aero chamber spacer, which will eventually drive the segment growth. The aerochamber spacer comprises a plastic tube, a valve, a mouthpiece, and a soft sealed end to hold the metered-dose inhaler. The chamber enables the delivery of medicine to the small airways in the lungs. This process catalyzes the drug's effectiveness.

Place a Purchase Order to Buy a Complete Copy of this Report @ https://www.theinsightpartners.com/buy/TIPRE00004918/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

This release was published on openPR.